ask="16.19"
ask_size="800"
average_daily_volume="544082"
bid="14.60"
bid_size="4100"
book_value="9.23"
change="+1.55"
change_from_200_day_moving_average="-6.06"
change_from_50_day_moving_average="0.78"
change_from_52_week_high="-30.60"
change_From_52_week_low="4.18"
change_in_percent="+11.88%"
close="14.60"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.73"
ebitda="-119.41M"
eps_estimate_current_year="-2.82"
eps_estimate_next_quarter="-0.80"
eps_estimate_next_year="-3.28"
ex_dividend_date="N/A"
float_shares="34396000"
high="14.78"
high_52_weeks="45.20"
last_trade_date="3/1/2017"
last_trade_price="14.60"
last_trade_size="41661"
last_trade_time="4:00pm"
low="10.43"
low_52_weeks="10.43"
market_capitalization="631.71M"
moving_average_200_day="20.66"
moving_average_50_day="13.82"
name="Intra-Cellular Therapies Inc."
notes="N/A"
one_year_target_price="35.63"
open="13.36"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-29.35%"
percent_change_from_50_day_moving_average="+5.68%"
percent_change_from_52_week_high="-67.70%"
percent_change_from_52_week_low="+40.05%"
previous_close="13.05"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.41"
price_per_sales="2143.15"
revenue="263466.00"
shares_outstanding="43268000"
short_ratio="11.23"
stock_exchange="NMS"
symbol="ITCI"
volume="2661837"
weeks_range_52="10.43 - 45.20"
